Continuous Glucose Monitoring

Latest News

FDA Clears First 1-Year CGM for Diabetes
FDA Clears First 1-Year CGM for Diabetes

September 18th 2024

The Eversense 365 is the world’s first long-term CGM that provides 1 year of use and should be available by the fourth quarter of 2024.

Abbott’s OTC Lingo CGM for Wellness Now Available
Abbott’s OTC Lingo CGM for Wellness Now Available

September 6th 2024

Dexcom’s OTC Continuous Glucose Monitor Now Available in US
Dexcom’s OTC Continuous Glucose Monitor Now Available in US

August 26th 2024

FDA Approves Medtronic’s Disposable CGM
FDA Approves Medtronic’s Disposable CGM

August 14th 2024

Intermittently Scanned CGM Can Reduce Hypoglycemic Episodes in T1D
Intermittently Scanned CGM Can Reduce Hypoglycemic Episodes in T1D

July 18th 2024

Latest CME Events & Activities

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

The Utilization of SGLT2 Inhibitors in the Treatment of Cardiovascular Disease, Diabetes, and Chronic Kidney D...

1.5 Credits / Cardiology; Endocrinology, Diabetes & Metabolism; Nephrology

View More

Integrated Continuous Glucose Monitoring Implementation and Connectivity: Best Practices, Featuring a Powered ...

1.5 Credit / Endocrinology, Diabetes & Metabolism

View More

Integrated Continuous Glucose Monitoring Implementation and Connectivity: Best Practices, Featuring a Powered ...

1.5 Credit / Endocrinology, Diabetes & Metabolism

View More

Reducing Barriers in Integrated Continuous Glucose Monitoring Use, Featuring Patient Counseling Video Vignette...

1.0 Credit / Endocrinology, Diabetes & Metabolism

View More

Reducing Barriers in Integrated Continuous Glucose Monitoring Use, Featuring Patient Counseling Video Vignette...

1.0 Credit / Endocrinology, Diabetes & Metabolism

View More

Integrated Continuous Glucose Monitoring: What’s New in 2024, Featuring a Device Demonstration and Patient Cou...

1.0 Credit / Endocrinology, Diabetes & Metabolism

View More

Integrated Continuous Glucose Monitoring: What’s New in 2024, Featuring a Device Demonstration and Patient Cou...

1.0 Credit / Endocrinology, Diabetes & Metabolism

View More

Strategies for Addressing Cardiovascular Disease, Diabetes, and Chronic Kidney Disease With SGLT2 Inhibitors

1.0 Credit / Endocrinology, Diabetes & Metabolism

View More

Reducing Endocrinopathies of Immune Checkpoint Inhibitor Therapy: Management Strategies for Oncology Pharmacis...

1.0 Credit / Oncology, Endocrinology, Diabetes & Metabolism

View More

Foundations in Continuous Glucose Monitoring

1.0 Credit / Endocrinology, Diabetes & Metabolism

View More

SimulatED: Using Continuous Glucose Monitoring Data to Improve Health Outcomes

0.75 Credit / Endocrinology, Diabetes & Metabolism

View More

SimulatED: Using Continuous Glucose Monitoring Data to Improve Health Outcomes (Pharmacy Technician Credit)

0.75 Credit / Endocrinology, Diabetes & Metabolism

View More

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Uncovering the Challenges in Treatment Pathways in AMD and DME

1.0 Credit / Endocrinology, Diabetes & Metabolism, Ophthalmology & Optometry

View More

Navigating Anti-Vascular Endothelial Growth Factor Therapy and Dosing Strategies

1.0 Credit / Endocrinology, Diabetes & Metabolism, Ophthalmology & Optometry

View More

Improving Patient Outcomes in AMD and DME Through the Integration of Specialty Pharmacy Care

1.0 Credit / Endocrinology, Diabetes & Metabolism, Ophthalmology & Optometry

View More

Best Practices for the Integration of Continuous Glucose Monitoring Within the Health System

1.5 Credits / Endocrinology, Diabetes & Metabolism

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

Best Practices for the Integration of Continuous Glucose Monitoring Devices Across Community Pharmacy Settings

1.5 Credits / Endocrinology, Diabetes & Metabolism

View More

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outc...

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

View More

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support I...

1.0 Credit / Endocrinology, Diabetes & Metabolism

View More

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support I...

1.0 Credit / Endocrinology, Diabetes & Metabolism

View More

Glucagon for Diabetes: Overcoming Barriers for Optimal Management in the Long-Term Care Setting

1.0 Credit / Endocrinology, Diabetes & Metabolism

View More

Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care an...

1.0 Credit / Cardiology, Endocrinology, Diabetes, & Metabolism, Nephrology

View More

More News

Continuous Glucose Monitors Useful to Predict Pre-Diabetes

Christine Blank
June 15th 2023

When employed as a prescreening tool, care must be taken to avoid overdiagnosis of healthy individuals without diabetes.

dexcom g6 | image credit: Dulin - stock.adobe.com

Pharmacists Applaud New Bionic Pancreas for Type 1 Diabetes

Christine Blank
June 15th 2023

The iLet Bionic Pancreas combines data from the Dexcom G6 CGM with different algorithms to deliver insulin throughout the day.

CGM Use May Lead to Behavioral Modifications in Adolescent T2D

CGM Use May Lead to Behavioral Modifications in Adolescent T2D

Lauren Biscaldi, MS, Managing Editor
June 14th 2023
Activity “Snacking” Can Benefit Individuals With T1D

Activity “Snacking” Can Benefit Individuals With T1D

Christine Blank
May 15th 2023

Doing small spurts of exercise throughout the day provide numerous benefits.

The Importance of Health Equity in Diabetes Care

The Importance of Health Equity in Diabetes Care

Christine Blank
May 15th 2023
CGM Technology Has a Role Outside of Diabetes Care

CGM Technology Has a Role Outside of Diabetes Care

Christine Blank
May 15th 2023

What can CGM's provide for individuals who don't have diabetes?

type 1 diabetes | Image Credit: adrian_ilie825 - stock.adobe.com

FDA Approval: Medtronic MiniMed 780G Insulin Pump System for T1D

Joshua Fitch
April 25th 2023

The MiniMed 780G has been available in Europe since 2020.

medication vial syringe | Image Credit: Daniel CHETRONI - stock.adobe.com

Sanofi Acquisition Will Further Distribution of T1D Therapy Teplizumab-mzwv

Christine Blank
April 17th 2023

The drug is the first and only therapy to delay the onset of stage 3 type 1 diabetes.

Insulin Cap Bill the Latest Action in Efforts to Slash Insulin Prices

Insulin Cap Bill the Latest Action in Efforts to Slash Insulin Prices

Christine Blank
April 17th 2023

Proposed legislation would cap the price of insulin at $35 for a 30-day supply.

woman using CGM device | Image Credit: Andrey Popov - stock.adobe.com

What’s New With Continuous Glucose Monitors

Christine Blank
April 7th 2023

Continuous glucose monitors are poised to change diabetes management for patients.

Eid holiday table. Ramadan family dinner. | Image credit: Fevziie - stock.adobe.com

Video: Tips for Medication Management During Ramadan

Lauren Biscaldi, MS, Managing Editor
March 29th 2023

Pharmacists can provide support and guidance to patients during their month of fasting.

Virtual Clinics Help Remove Barriers to Diabetes Care

Virtual Clinics Help Remove Barriers to Diabetes Care

Quinn Everts
March 20th 2023

Various issues were mitigated when patients were given proper training and supplies.

Initiation of Continuous Glucose Monitoring Reduced Hospitalizations for Diabetes, CKD

Initiation of Continuous Glucose Monitoring Reduced Hospitalizations for Diabetes, CKD

Quinn Everts
March 20th 2023

According to 2 conference abstracts, CGM’s are effective in treating T2D and chronic kidney disease, but more data may be required to complete the picture.

Safety, Accuracy of Dexcom G7 CGM Evaluated in T1D and T2D

Safety, Accuracy of Dexcom G7 CGM Evaluated in T1D and T2D

Lauren Biscaldi, MS, Managing Editor
March 20th 2023

The CGM provides accurate readings over 10.5 days of continuous wear.

Racial, Ethnic Inequities Persist in Diabetes Care

Racial, Ethnic Inequities Persist in Diabetes Care

Meg Marzella
March 6th 2023

Significant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors

Dexcom G7 Receives FDA Clearance for Patients with T2D and T1D

Dexcom G7 Receives FDA Clearance for Patients with T2D and T1D

Miranda Hester
December 8th 2022

Dexcom expects the device to launch in the United States early next year.

Black Patients Face Disparities for CGMs, Insulin Pumps

Black Patients Face Disparities for CGMs, Insulin Pumps

Staff Writer
November 29th 2022

New research adds more evidence of Black patients facing disparities in diabetes care.

Increased Scanning with CGM Improves Glucose Control in T1D

Increased Scanning with CGM Improves Glucose Control in T1D

Staff Writer
October 31st 2022

Research shows that an increase in intermittent scanning helps improve glycemic control and reduce the fear of hypoglycemia.

Improved Glycemic Control, Time in Range for Type 1 Diabetes Found with Flash Glucose Monitoring

Improved Glycemic Control, Time in Range for Type 1 Diabetes Found with Flash Glucose Monitoring

Staff Writer
October 13th 2022

Examining the benefits of using flash glucose monitoring in patients with type 1 diabetes.

Improved Glycemic Control, Time in Target Range Found with iLet Bionic Pancreas

Improved Glycemic Control, Time in Target Range Found with iLet Bionic Pancreas

Staff Writer
September 29th 2022

The iLet Bionic Pancreas was associated with improved glycemic control and time in target glucose range compared to standard care in a cohort of people with type 1 diabetes aged 6-79 years of age.

Number of People with Type 1 Diabetes Forecasted to Double by 2040

Number of People with Type 1 Diabetes Forecasted to Double by 2040

Staff Writer
September 22nd 2022

Modeling indicates a significant increase in patients with type 1 diabetes over the next several years.

Open-Source Automated Insulin Delivery Systems May Lead to Glycemic Control Improvement in Type 1 Diabetes

Open-Source Automated Insulin Delivery Systems May Lead to Glycemic Control Improvement in Type 1 Diabetes

Staff Writer
September 19th 2022

Research indicates that using an open-source automated insulin delivery systems can lead to greater glycemic control.

Improving Glycemic Markers in Children with Type 1 Diabetes Using Technology

Improving Glycemic Markers in Children with Type 1 Diabetes Using Technology

Miranda Hester
September 9th 2022

Software updates in closed-loop systems may lead to better time in range numbers for children with type 1 diabetes.

Glycemic Control in Teenagers with Type 1 Diabetes Could Be Key to Stave Off Neurological Damage

Glycemic Control in Teenagers with Type 1 Diabetes Could Be Key to Stave Off Neurological Damage

Staff Writer
September 6th 2022

Improved glycemic control could reduce the risk of diabetes-related brain damage among teens and adolescents with type 1 diabetes.

Continuous Glucose Monitoring and Its Part in Diabetes Management

Continuous Glucose Monitoring and Its Part in Diabetes Management

Diana Issacs, PharmD, BCPS, BCACP, BC-ADM, CDCES
June 2nd 2022

Continuous glucose monitoring has many benefits and can improve disease management in for both diabetes types.

<1234>
© 2024 MJH Life Sciences

All rights reserved.